Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWO
2926
Two Harbors Investment
TWO
$1.27B
| $511K | ﹤0.01% |
38,688
-53,255
| -58% | -$677K |
|
|
CCRN
2927
DELISTED
Cross Country Healthcare
CCRN
| $511K | ﹤0.01% |
36,905
-5,658
| -13% | -$89.6K |
|
2928
AnaptysBio
ANAB
$1.67B
| $511K | ﹤0.01% |
20,374
-8,948
| -31% | -$208K |
|
2929
Tactile Systems Technology
TCMD
$652M
| $510K | ﹤0.01% |
42,697
-6,456
| -13% | -$86.9K |
|
2930
Northwest Natural Holdings
NWN
$2.12B
| $509K | ﹤0.01% |
14,097
-18,966
| -57% | -$701K |
|
2931
Aspen Aerogels
ASPN
$518M
| $507K | ﹤0.01% |
21,278
-26,764
| -56% | -$628K |
|
|
BRY
2932
DELISTED
Berry Corp
BRY
| $507K | ﹤0.01% |
78,427
-42,994
| -35% | -$320K |
|
|
EFC
2933
Ellington Financial
EFC
$1.72B
| $506K | ﹤0.01% |
41,915
-26,201
| -38% | -$309K |
|
|
GRAL
2934
GRAIL Inc
GRAL
$2.94B
| $506K | ﹤0.01% |
+32,911
| New | +$534K |
|
2935
CALL
SolarEdge
SEDG
$1.95B
| $505K | ﹤0.01% |
20,000
-60,000
| -75% | -$3.12M |
|
2936
Bank of Marin Bancorp
BMRC
$461M
| $503K | ﹤0.01% |
31,064
+401
| +1% | +$6.17K |
|
2937
Southern First Bancshares
SFST
$598M
| $503K | ﹤0.01% |
17,192
-2,971
| -15% | -$81.5K |
|
|
ONT
2938
Onterris Inc
ONT
$602M
| $503K | ﹤0.01% |
11,278
-17,719
| -61% | -$797K |
|
2939
Grocery Outlet
GO
$967M
| $502K | ﹤0.01% |
22,687
-165,352
| -88% | -$3.92M |
|
2940
Olema Pharmaceuticals
OLMA
$1.04B
| $501K | ﹤0.01% |
46,301
+3,491
| +8% | +$37.9K |
|
2941
Brookdale Senior Living
BKD
$3.42B
| $501K | ﹤0.01% |
73,349
-98,374
| -57% | -$665K |
|
2942
Mid Penn Bancorp
MPB
$953M
| $501K | ﹤0.01% |
22,819
-8,101
| -26% | -$168K |
|
2943
First Watch Restaurant Group
FWRG
$770M
| $500K | ﹤0.01% |
28,501
-21,310
| -43% | -$445K |
|
2944
El Pollo Loco
LOCO
$468M
| $498K | ﹤0.01% |
44,075
-21,263
| -33% | -$212K |
|
2945
Orion
OEC
$411M
| $498K | ﹤0.01% |
22,719
-28,182
| -55% | -$678K |
|
2946
West Fraser Timber
WFG
$5.59B
| $498K | ﹤0.01% |
6,472
-78,273
| -92% | -$6.21M |
|
2947
Anika Therapeutics
ANIK
$281M
| $497K | ﹤0.01% |
19,610
-8,244
| -30% | -$214K |
|
2948
TFS Financial
TFSL
$4.97B
| $496K | ﹤0.01% |
39,323
-21,994
| -36% | -$277K |
|
|
ATXS
2949
DELISTED
Astria Therapeutics
ATXS
| $494K | ﹤0.01% |
54,330
-80,877
| -60% | -$790K |
|
|
OLPX
2950
DELISTED
Olaplex Holdings
OLPX
| $494K | ﹤0.01% |
321,016
+139,974
| +77% | +$223K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.